Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hui-Juan Qiu

Showing results (11-20 of 31) with videos related to

Pageof 4
Sort By:
Medical Oncology (Northwood, London, England)|July 24, 2010
Knockdown of eIF4E suppresses cell growth and migration, enhances chemosensitivity and correlates with increase in Bax/Bcl-2 ratio in triple-negative breast cancer cellsFei-fei Zhou, Min Yan, Gui-fang Guo, et al.
AI Zheng = Aizheng = Chinese Journal of Cancer|December 5, 2009
[Efficacy of cetuximab combined with chemotherapy on advanced colorectal cancer: a report of 53 cases]Gui-Fang Guo, Liang-Ping Xia, Bei Zhang, et al.
Medical Oncology (Northwood, London, England)|October 23, 2010
Short-term outcomes of cetuximab combined with standard chemotherapy as first line setting for Chinese patients with non-small cell lung cancer: a report of 12 casesLiang-Ping Xia, Hui-Juan Qiu, Xu-Xian Chen, et al.
Plos One|April 11, 2013
Decreased expression of Beclin 1 correlates closely with Bcl-xL expression and poor prognosis of ovarian carcinomaHuan-Xin Lin, Hui-Juan Qiu, Fei Zeng, et al.
AI Zheng = Aizheng = Chinese Journal of Cancer|November 28, 2002
[Treatment of hepatic functional reserve injury after TACE in hepatocellular carcinoma with Chinese herbal medicines]Xun-xian Chen, Bei Zhang, Ya-qi Zhang, et al.
Cancer Biology & Medicine|May 22, 2013
Initial Progression-Free Survival after Non-First Line TKIs Therapy Potentially Guides Immediate Treatment after Its Failure in Advanced Non-Small Cell Lung CancerFang Wang, Gui-Fang Guo, Hui-Juan Qiu, et al.
Medical Oncology (Northwood, London, England)|November 17, 2010
Overexpression of SGLT1 and EGFR in colorectal cancer showing a correlation with the prognosisGui Fang Guo, Yu Chen Cai, Bei Zhang, et al.
Plos One|January 26, 2013
BIRB796, the inhibitor of p38 mitogen-activated protein kinase, enhances the efficacy of chemotherapeutic agents in ABCB1 overexpression cellsDan He, Xiao-qin Zhao, Xing-gui Chen, et al.
Cancer Management and Research|June 29, 2018
An increased number of negative lymph nodes is associated with a higher immune response and longer survival in colon cancer patientsWen-Zhuo He, Qian-Kun Xie, Wan-Ming Hu, et al.
Asian Pacific Journal of Cancer Prevention : APJCP|July 22, 2014
Efficacy of taxane-based regimens in a first-line setting for recurrent and/or metastatic Chinese patients with esophageal cancerChang Jiang, Fang-Xin Liao, Yu-Ming Rong, et al.
Pageof 4

Showing results (11-20 of 31) with videos related to

Sort By:
Pageof 4
Medical Oncology (Northwood, London, England)|July 24, 2010
Knockdown of eIF4E suppresses cell growth and migration, enhances chemosensitivity and correlates with increase in Bax/Bcl-2 ratio in triple-negative breast cancer cellsFei-fei Zhou, Min Yan, Gui-fang Guo, et al.
AI Zheng = Aizheng = Chinese Journal of Cancer|December 5, 2009
[Efficacy of cetuximab combined with chemotherapy on advanced colorectal cancer: a report of 53 cases]Gui-Fang Guo, Liang-Ping Xia, Bei Zhang, et al.
Medical Oncology (Northwood, London, England)|October 23, 2010
Short-term outcomes of cetuximab combined with standard chemotherapy as first line setting for Chinese patients with non-small cell lung cancer: a report of 12 casesLiang-Ping Xia, Hui-Juan Qiu, Xu-Xian Chen, et al.
Plos One|April 11, 2013
Decreased expression of Beclin 1 correlates closely with Bcl-xL expression and poor prognosis of ovarian carcinomaHuan-Xin Lin, Hui-Juan Qiu, Fei Zeng, et al.
AI Zheng = Aizheng = Chinese Journal of Cancer|November 28, 2002
[Treatment of hepatic functional reserve injury after TACE in hepatocellular carcinoma with Chinese herbal medicines]Xun-xian Chen, Bei Zhang, Ya-qi Zhang, et al.
Cancer Biology & Medicine|May 22, 2013
Initial Progression-Free Survival after Non-First Line TKIs Therapy Potentially Guides Immediate Treatment after Its Failure in Advanced Non-Small Cell Lung CancerFang Wang, Gui-Fang Guo, Hui-Juan Qiu, et al.
Medical Oncology (Northwood, London, England)|November 17, 2010
Overexpression of SGLT1 and EGFR in colorectal cancer showing a correlation with the prognosisGui Fang Guo, Yu Chen Cai, Bei Zhang, et al.
Plos One|January 26, 2013
BIRB796, the inhibitor of p38 mitogen-activated protein kinase, enhances the efficacy of chemotherapeutic agents in ABCB1 overexpression cellsDan He, Xiao-qin Zhao, Xing-gui Chen, et al.
Cancer Management and Research|June 29, 2018
An increased number of negative lymph nodes is associated with a higher immune response and longer survival in colon cancer patientsWen-Zhuo He, Qian-Kun Xie, Wan-Ming Hu, et al.
Asian Pacific Journal of Cancer Prevention : APJCP|July 22, 2014
Efficacy of taxane-based regimens in a first-line setting for recurrent and/or metastatic Chinese patients with esophageal cancerChang Jiang, Fang-Xin Liao, Yu-Ming Rong, et al.
Pageof 4